Curtin Drug Inc
Community/Retail Pharmacy
1055 W 121st St S Ste 101, Jenks
Oklahoma, 74037-4267
918-528-6000 918-528-6060
Curtin Drug Inc is an authorized DME supplier for medicare equipments and products.
Curtin Drug Inc is a Community/Retail Pharmacy in Jenks, Oklahoma. It is located at 1055 W 121st St S Ste 101, Jenks and it's customer support contact number is 918-528-6000. The authorized person of Curtin Drug Inc is Nick Curtin, PHARMD who is President of the pharmacy and his contact number is 918-528-6000. Active license number of Curtin Drug Inc is 25659 for Community/Retail Pharmacy in Oklahoma. Curtin Drug Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Curtin Drug Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Curtin Drug Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Curtin Drug Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 1055 W 121st St S Ste 101, Jenks, Oklahoma, 74037-4267 |
| Phone: | 918-528-6000 |
| Fax: | 918-528-6060 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Nick Curtin |
| Credentials: | PHARMD |
| Position: | President |
| Contact Number: | 918-528-6000 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1962682757 |
| NPI Enumeration Date: | 08 Nov, 2007 |
| NPI Last Update On: | 31 Jul, 2025 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Curtin Drug Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 25659 | Oklahoma | Primary | |
| Compounding Pharmacy | | | Secondary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 200124590A | Medicaid | Oklahoma | |
| 2133871 | Other | | Pk |
Medicare Enrollment:
Curtin Drug Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 0446484364 | O20131009000494 | Curtin Drug Inc | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1055 W 121st St S Ste 101, Jenks, Oklahoma |
| Zip: | 74037-4267 |
| Phone Number: | 918-528-6000 |
| Fax Number: | 918-528-6060 |
Patients can reach Curtin Drug Inc at
1055 W 121st St S Ste 101, Jenks, Oklahoma or can
call on customer care at 918-528-6000.
Comments/ Reviews:
Read all the reviews posted for Curtin Drug Inc below. You may also share your own experience with Curtin Drug Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.